Main > NEUROLOGY. > Epilepsy > Treatment > Co: PT. B. Eslicarbazepine Acetate
Co: PT. B. Eslicarbazepine Acetate's subsections
(*) CA Approval Date: ?>
(*) EU 1st Approval: 2009.04>
(*) EU 2nd Approval: 2016.12>
(*) EU 3rd Approval: 2017.03>
(*) USA 1st Approval: ?>
(*) USA 2nd Approval: 2017. 09.14.>
Company/Licensee CA USA
Company/Licensee EU
Company/Licensor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2017. 09.12
POS: Partial Onset Seizure
TradeMark EU
TradeMark USA
TradeMark USA Web-Site
Co: PT. B. Eslicarbazepine Acetate's products
This section has no products